While IL-12 has been highly studied for tumor therapy (116–119), there are many other mRNA-based proinflammatory cytokine therapies that are also under investigation involving the use of IFNγ (120), IL-2 (121), and IL-15 (122). Here, IFNG is linked to neoplasm.